Few cancer centers comply with price transparency law, analysis finds

Out of 63 National Cancer Institute-designated cancer centers in the U.S., only one-third are fully compliant with federal price transparency rules, according to an Aug. 10 analysis published in JAMA Surgery.

Advertisement

The federal rule took effect Jan. 1, 2021, and requires hospitals to disclose five types of standard charges for all services in a consumer-friendly display. In August 2021, 42 of the 63 cancer hospitals provided some information on negotiated rates, while only 20 of the 63 were fully compliant. 

The analysis noted that compliance will likely increase over time as the federal government enforces the mandate.

Cancer patient care is one of the largest segments of healthcare spending in the U.S., estimated at approximately $208.9 billion annually.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.